Pages that link to "Q41927429"

The following pages link to Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1 (Q41927429):

Displaying 39 items.

• Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes. (Q30359528) (← links)
• Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure? (Q30362489) (← links)
• Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial (Q30402402) (← links)
• The anti-HIV-1 activity of chloroquine (Q31884593) (← links)
• Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation (Q33613674) (← links)
• Management of HIV-infected pregnant patients in malaria-endemic areas: therapeutic and safety considerations in concomitant use of antiretroviral and antimalarial agents (Q33745955) (← links)
• Effects of chloroquine on viral infections: an old drug against today's diseases? (Q33973620) (← links)
• Reduction of immune activation with chloroquine therapy during chronic HIV infection (Q34296062) (← links)
• Lysosomotropic agents as HCV entry inhibitors. (Q34957340) (← links)
• HIV transmission through breastfeeding: problems and prevention (Q35153151) (← links)
• Effect of chloroquine on human immunodeficiency virus (HIV) vertical transmission. (Q36276294) (← links)
• Chronic use of chloroquine disrupts the urine concentration mechanism by lowering cAMP levels in the inner medulla (Q36309457) (← links)
• Alternative modified infant-feeding practices to prevent postnatal transmission of human immunodeficiency virus type 1 through breast milk: past, present, and future (Q36391604) (← links)
• Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century (Q36880738) (← links)
• The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1. (Q37062264) (← links)
• Chloroquine is effective against influenza A virus in vitro but not in vivo (Q37087650) (← links)
• Rheumatic conditions in human immunodeficiency virus infection (Q37138780) (← links)
• Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents (Q37245300) (← links)
• Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial (Q37289596) (← links)
• Serious Non-AIDS events: Immunopathogenesis and interventional strategies (Q37418140) (← links)
• The role and therapeutic potential of autophagy modulation in controlling virus-induced cell death. (Q38152376) (← links)
• Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS. (Q38530430) (← links)
• Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection (Q38749963) (← links)
• Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy (Q39048479) (← links)
• Immunosenescence and hurdles in the clinical management of older HIV-patients (Q39170367) (← links)
• Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy. (Q39798599) (← links)
• Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection (Q39964308) (← links)
• The ability of chloroquine to prevent tat-induced cytokine secretion by monocytes is implicated in its in vivo anti-human immunodeficiency virus type 1 activity. (Q40213471) (← links)
• Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1. (Q41917540) (← links)
• The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea (Q41919627) (← links)
• Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy (Q41921243) (← links)
• Use of chloroquine in viral diseases (Q41932841) (← links)
• Antiretroviral treatment (Q42538941) (← links)
• Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies (Q43280688) (← links)
• HIV as a Cause of Immune Activation and Immunosenescence (Q47151081) (← links)
• Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. (Q54218397) (← links)
• The Use of Antimalarial Drugs against Viral Infection (Q92633499) (← links)
• Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review (Q94590927) (← links)
• Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review (Q96018078) (← links)